H. B. Fuller (NYSE:FUL – Get Free Report) had its price objective decreased by equities researchers at JPMorgan Chase & Co. from $67.00 to $66.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 33.72% from the company’s current price.
Several other equities research analysts have also issued reports on FUL. Wall Street Zen lowered shares of H. B. Fuller from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 25th. The Goldman Sachs Group set a $67.00 price objective on H. B. Fuller in a report on Friday, June 26th. Robert W. Baird lowered their target price on H. B. Fuller from $75.00 to $65.00 and set an “outperform” rating on the stock in a research report on Friday. UBS Group set a $69.00 target price on H. B. Fuller in a report on Friday, June 26th. Finally, Citigroup reduced their price target on H. B. Fuller from $75.00 to $63.00 and set a “buy” rating for the company in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $65.88.
Read Our Latest Report on H. B. Fuller
H. B. Fuller Stock Down 1.4%
H. B. Fuller (NYSE:FUL – Get Free Report) last posted its quarterly earnings data on Thursday, September 24th. The specialty chemicals company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.05. The company had revenue of $938.17 million for the quarter, compared to the consensus estimate of $945.59 million. H. B. Fuller had a net margin of 5.56% and a return on equity of 12.65%. The firm’s revenue was up 5.2% compared to the same quarter last year. During the same period last year, the company earned $1.26 earnings per share. As a group, analysts expect that H. B. Fuller will post 4.78 EPS for the current fiscal year.
Insider Activity at H. B. Fuller
In other news, VP Nathan Weaver sold 9,561 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $62.06, for a total transaction of $593,355.66. Following the transaction, the vice president directly owned 11,739 shares in the company, valued at $728,522.34. The trade was a 44.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.83% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On H. B. Fuller
A number of institutional investors and hedge funds have recently modified their holdings of the company. Ellevest Inc. raised its stake in H. B. Fuller by 7.2% in the fourth quarter. Ellevest Inc. now owns 3,626 shares of the specialty chemicals company’s stock valued at $216,000 after purchasing an additional 245 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in H. B. Fuller by 4.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 10,657 shares of the specialty chemicals company’s stock worth $634,000 after buying an additional 450 shares in the last quarter. Parallel Advisors LLC increased its holdings in H. B. Fuller by 85.6% in the 1st quarter. Parallel Advisors LLC now owns 1,034 shares of the specialty chemicals company’s stock valued at $64,000 after buying an additional 477 shares during the period. Inspire Investing LLC increased its holdings in H. B. Fuller by 6.3% in the 1st quarter. Inspire Investing LLC now owns 8,362 shares of the specialty chemicals company’s stock valued at $516,000 after buying an additional 499 shares during the period. Finally, Hantz Financial Services Inc. raised its position in shares of H. B. Fuller by 432.9% in the 4th quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company’s stock valued at $46,000 after buying an additional 632 shares in the last quarter. 95.93% of the stock is owned by institutional investors.
About H. B. Fuller
H.B. Fuller Company (NYSE: FUL) develops and manufactures specialty adhesives, sealants and other chemical-based products used in industrial and commercial applications. Its solutions help customers bond, seal, coat and assemble materials across a range of products and manufacturing processes.
The company serves markets including packaging, hygiene and disposable products, construction, transportation, electronics, durable assembly, woodworking, flooring, composites and renewable energy.
See Also
- Five stocks we like better than H. B. Fuller
- 2 China-Focused ETFs For After the Trump-Xi Summit
- 3 Dividend Stocks Investors May Be Missing in 2026
- 3 Healthcare Stocks Showing Why the Sector Still Has Momentum
- Akamai’s Anthropic Deal Puts $5.5 Billion Behind Its Edge AI Pivot
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
